Claire Vale
iris.ucl.ac.uk
0000-0001-5157-0634
University College London
54 papers found
Refreshing results…
Meta-analyses based on summary data can provide timely, thorough and reliable evidence: don’t dismiss them yet
Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
A framework for prospective, adaptive meta-analysis (FAME) of aggregate data from randomised trials
Postoperative radiotherapy in prostate cancer – Authors' reply
Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings
Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data
Methods used to assess outcome consistency in clinical studies: A literature-based evaluation
Cytoreductive surgery (CRS) with hyperthermic intraoperative peritoneal chemotherapy (HIPEC) versus standard of care (SoC) in people with peritoneal metastases from colorectal, ovarian or gastric origin: protocol for a systematic review and individual participant data (IPD) meta-analyses of effectiveness and cost-effectiveness
“PROUD to have been involved”: an evaluation of participant and community involvement in the PROUD HIV prevention trial
Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis
Effectiveness and acceptability of methods of communicating the results of clinical research to lay and professional audiences: protocol for a systematic review
Reply to Comments on “Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis”
Evidence Synthesis to Accelerate and Improve the Evaluation of Therapies for Metastatic Hormone-sensitive Prostate Cancer
Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis
Response to letter commenting on published paper: Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis
Re: Christopher J.D. Wallis, Zachary Klaassen, Bimal Bhindi, et al. Comparison of Abiraterone Acetate and Docetaxel with Androgen Deprivation Therapy in High-risk and Metastatic Hormone-naïve Prostate Cancer: A Systematic Review and Network Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.10.002
What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysis
When participants get involved: reconsidering patient and public involvement in clinical trials at the MRC Clinical Trials Unit at UCL
Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis
Missing publications? Search for publications with a matching author name.